Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- PMID: 24162737
- PMCID: PMC3896259
- DOI: 10.1038/ng.2802
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Abstract
Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous studies; however, a large portion of the genetic risk for this disease remains unexplained. We conducted a large, two-stage meta-analysis of genome-wide association studies (GWAS) in individuals of European ancestry. In stage 1, we used genotyped and imputed data (7,055,881 SNPs) to perform meta-analysis on 4 previously published GWAS data sets consisting of 17,008 Alzheimer's disease cases and 37,154 controls. In stage 2, 11,632 SNPs were genotyped and tested for association in an independent set of 8,572 Alzheimer's disease cases and 11,312 controls. In addition to the APOE locus (encoding apolipoprotein E), 19 loci reached genome-wide significance (P < 5 × 10(-8)) in the combined stage 1 and stage 2 analysis, of which 11 are newly associated with Alzheimer's disease.
Figures


References
-
- Corder EH, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921–923. - PubMed
-
- Lambert J-C, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat. Genet. 2009;41:1094–1099. - PubMed
Publication types
MeSH terms
Grants and funding
- MR/K013041/1/MRC_/Medical Research Council/United Kingdom
- G0300329/MRC_/Medical Research Council/United Kingdom
- G0900635/MRC_/Medical Research Council/United Kingdom
- U01 AG032984/AG/NIA NIH HHS/United States
- G0600974/MRC_/Medical Research Council/United Kingdom
- UL1 TR000124/TR/NCATS NIH HHS/United States
- G0500289/MRC_/Medical Research Council/United Kingdom
- R01 AG033193/AG/NIA NIH HHS/United States
- R01 AG023629/AG/NIA NIH HHS/United States
- R01 AG015819/AG/NIA NIH HHS/United States
- G0801306/MRC_/Medical Research Council/United Kingdom
- U01 HG006375/HG/NHGRI NIH HHS/United States
- MC_U123160657/MRC_/Medical Research Council/United Kingdom
- R01 AG016495/AG/NIA NIH HHS/United States
- P50 AG005131/AG/NIA NIH HHS/United States
- U24 AG021886/AG/NIA NIH HHS/United States
- K25 AG041906/AG/NIA NIH HHS/United States
- MC_U123160651/MRC_/Medical Research Council/United Kingdom
- P30 AG062421/AG/NIA NIH HHS/United States
- MC_U105292687/MRC_/Medical Research Council/United Kingdom
- P50 AG008702/AG/NIA NIH HHS/United States
- U01 AG016976/AG/NIA NIH HHS/United States
- P30 AG008051/AG/NIA NIH HHS/United States
- P30 AG013846/AG/NIA NIH HHS/United States
- U24 AG056270/AG/NIA NIH HHS/United States
- R01 AG017917/AG/NIA NIH HHS/United States
- MC_U137686857/MRC_/Medical Research Council/United Kingdom
- G0902227/MRC_/Medical Research Council/United Kingdom
- 089703/WT_/Wellcome Trust/United Kingdom
- R01 HL105756/HL/NHLBI NIH HHS/United States
- G1100695/MRC_/Medical Research Council/United Kingdom
- P50 AG016573/AG/NIA NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- R01 AG008122/AG/NIA NIH HHS/United States
- P50 AG005134/AG/NIA NIH HHS/United States
- R01 NS080820/NS/NINDS NIH HHS/United States
- G0900688/MRC_/Medical Research Council/United Kingdom
- G0601846/MRC_/Medical Research Council/United Kingdom
- ARC_/Arthritis Research UK/United Kingdom
- R01 AG041797/AG/NIA NIH HHS/United States
- R01 AG041232/AG/NIA NIH HHS/United States
- P50 AG005138/AG/NIA NIH HHS/United States
- R01 AG037212/AG/NIA NIH HHS/United States
- 095317/WT_/Wellcome Trust/United Kingdom
- 100140/WT_/Wellcome Trust/United Kingdom
- MC_G1000734/MRC_/Medical Research Council/United Kingdom
- U01 AG049505/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous